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Abstract
Background: It is unclear whether a short-term change in circulating androgens is associated with changes in the 
transcriptome of the peripheral blood mononuclear cells (PBMC). 
Aims and methods: To explore the effect of hCG stimulation on the PBMC transcriptome, 12 boys with a median 
age (range) of 0.7 years (0.3, 11.2) who received intramuscular hCG 1500u on 3 consecutive days as part of their 
investigations underwent transcriptomic array analysis on RNA extracted from peripheral blood mononuclear cells 
before and after hCG stimulation. 
Results: Median pre- and post-hCG testosterone for the overall group was 0.7 nmol/L (<0.5, 6) and 7.9 nmol/L (<0.5, 
31.5), respectively. Of the 12 boys, 3 (25%) did not respond to hCG stimulation with a pre and post median serum 
testosterone of <0.5 nmol/L and <0.5 nmol/L, respectively. When corrected for gene expression changes in the non-
responders to exclude hCG effects, all 9 of the hCG responders consistently demonstrated a 20% or greater increase 
in the expression of piR-37153 and piR-39248, non-coding PIWI-interacting RNAs (piRNAs). In addition, of the 9 
responders, 8, 6 and 4 demonstrated a 30, 40 and 50% rise, respectively, in a total of 2 further piRNAs. In addition, 
3 of the responders showed a 50% or greater rise in the expression of another small RNA, SNORD5. On comparing 
fold-change in serum testosterone with fold-change in the above transcripts, a positive correlation was detected for 
SNORD5 (P = 0.01).
Conclusions: The identification of a dynamic and androgen-responsive PBMC transcriptome extends the potential 
value of the hCG test for the assessment of androgen sufficiency.
Introduction
Sex-specific differences in anatomic, physiological and 
behavioural phenotypes are commonly found in many 
species, including humans, and are considered to be due to 
a combination of the effect of sex hormones and genetics 
(1). These sex differences are also illustrated by tissue-
specific gene expression in several organs (2). The existence 
of an altered pattern of gene expression in androgen-
responsive tissues, such as genital skin fibroblasts obtained 
from people with androgen insensitivity syndrome (AIS) 
(3), points to the likelihood that this sex-specific gene 
expression is, at least, partly androgen dependent. It 
has also been suggested that the altered transcriptomic 
patterns observed in the genital skin fibroblasts in AIS 
may be due to long-term, programmed effects of altered 
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androgen signalling during prenatal development (4). 
However, changes in circulating proteins, such as sex 
hormone-binding globulin (SHBG), can occur over a 
period of few days following androgen exposure, and 
this change has been used to assess androgen sensitivity, 
sometimes after stimulation of testosterone production 
with human chorionic gonadotropin (hCG) (5, 6). It 
is unclear whether androgens, in this context, can also 
induce short-term changes in gene expression. Widespread 
and acute changes in gene expression in response to 
androgens have indeed been described in other models 
(7). The current study was, therefore, performed to 
investigate the existence of an androgen-responsive gene 
expression pattern that would change over a relatively 
short period in boys in response to androgens. Given that 
a sex-specific gene expression pattern exists in peripheral 
blood mononuclear cells (PBMCs), which are known to 
express the androgen receptor (AR) (8, 9), the study was 
specifically designed at studying transcriptional changes 
in these cells in a group of boys undergoing investigations 
for a suspected disorder of sex development (DSD) by 
hCG stimulation. It was anticipated that not only would 
this study provide valuable insight into the wider effects 
of androgens, but it would also improve the utility of 
the hCG stimulation test and the diagnosis of functional 
androgen deficiency.
Methods
Patients
Between 2011 and 2014, 12 boys attending the endocrine 
service at the Royal Hospital for Children, Glasgow for 
an hCG stimulation test for investigation of 46, XY 
DSD were recruited following informed consent. The 
hCG stimulation protocol included intramuscular hCG 
(Pregnyl, Organon) 1500u on 3 consecutive days with 
blood sampling on Day 1, immediately before the first 
injection, and on Day 4, a day after the third injection. At 
each visit, the boys were also examined and the External 
Masculinisation Score (EMS) was calculated as described 
before (10). The group of boys was divided into two 
groups, those with an EMS of less than 8 and another with 
an EMS of 8 or more.
Hormone assays and AR gene analysis
All blood samples were collected in the morning, processed 
and stored at −20°C. Gonadotrophins were measured 
by a chemiluminescent microparticle immunoassay on 
the Architect ci1600 (Abbott  Laboratories Diagnostics, 
Chicago,  IL). The lower limit of follicle-stimulating 
hormone (FSH) and luteinising hormone (LH) detection 
was 0.1 IU/L and inter- and intra-assay precision 
(coefficient of variation, CV) for both LH and FSH 
were less than 5% at levels of 0.2 IU/L and 2.3 IU/L for 
LH and 0.6 IU/L and 4.7 IU/L for FSH. Anti-Mullerian 
hormone (AMH) was measured using enzyme-linked 
immunosorbent assay using Beckman Gen II assay 
(Beckman Coulter, Indianopolis, IN). The functional 
sensitivity was 1.5 pmol/L and the inter- and intra-assay 
CVs over the concentration range of 5–70 pmol/L, was 
3.8–17.3% and 5.3–11.4%, respectively. Total testosterone 
and androstenedione were measured by LC MS/MS as 
described previously (11) using the Xevo TQS Tandem 
Mass Spectrometer (Waters Corporation, Milford, 
MA). Steroids were extracted from serum/plasma using 
Biotage supported liquid extraction (SLE), automated 
on the CTC PAL (MicroLiter Analytical Supplies Inc, 
Suwanne, Georgia), followed by Ultra-Performance 
Liquid Chromatographic separation. The lower limits 
of testosterone and androstenedione detection were 
0.18 nmol/L and 0.09 nmol/L, respectively. Where a 
baseline testosterone level was not available due to poor 
sample quality, a previous recent testosterone level was 
used. The AR gene (AR) for each patient was analysed by 
Sanger sequencing.
RNA extraction
For RNA extraction, blood was collected into EDTA and red 
cell lysis solution (Qiagen) was added. A total white cell 
count was performed and mononuclear cells were isolated 
by Ficoll gradient centrifugation. Total RNA was extracted 
from these cells on the Qiacube (Qiagen) with an RNA 
blood mini kit (Qiagen) according to the manufacturer’s 
instructions. The RNA was resuspended in nuclease-free 
dH2O and concentration was measured using the Nanodrop 
Spectrophotometer (Thermo Fisher Scientific) before being 
stored at −80°C in aliquots. RNA integrity numbers (RIN) 
were calculated using the Agilent 2100 Bioanalyser, version 
2.6 (Agilent). Median white cell count on Day 1 and 4 
was 12.6 × 109/L (6.3, 26.4) and 17.2 × 109/L (2.7, 25.5) 
respectively (P = 0.77). Median RNA concentration in the 
samples collected on Day 1 and 4 was 75 ng/µL (46, 117) 
and 62 ng/µL (16, 128), respectively (P = 0.88). Median RIN 
was also similar in the samples on Day 1 and 4 at 8.7 (3.8, 
9.4) and 7.6 (3.8, 9.7), respectively (P = 0.90).
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Microarray
The WT plus kit (Affymetrix) was used to prepare 
amplified and biotinylated sense-stranded DNA targets 
using a reverse transcription priming method. After 
reverse transcription with random primers, microarray 
hybridization was performed on Human Transcript Array 
(HTA) 2.0 (Affymetrix) for all 12 paired RNA samples. The 
HTA 2.0 design contains more than 6  million distinct 
probes covering coding and non-coding transcripts. 
Seventy  percent of the probes cover exons for coding 
transcripts, and the remaining 30% of probes on the 
array cover exon–exon splice junctions and non-coding 
transcripts. For simplicity, transcript clusters are described 
as genes. 
Transcriptome analysis
Robust Multi-array Average (RMA) normalization was 
performed using Transcriptome Analysis Console 
2.0 (Affymetrix) and then unsupervised hierarchical 
clustering analysis was performed in Partek Genomic Suite 
(Partek Inc, St Louis, MO). Gene expression data were 
log transformed and subsequent analysis was performed 
using Significance Analysis of Microarrays (SAM) package 
in the publicly available statistical computing language 
R (http://www.r-project.org). The programme was run 
using the response type as ‘two class unpaired’ based on 
100 permutations using SAM, version 5.0. The significant 
genes were selected on the combined criteria of ≤5% 
false discovery rate and ≥1.5 fold-change score. Gene 
transcripts were identified using The Human Genome 
Browser at UCSC (12). The cases were divided into those 
whose serum testosterone rose on hCG stimulation 
(responders) and those who did not show a testosterone 
rise (non-responders). To exclude the possible effects of 
hCG, as opposed to testosterone, on gene expression, 
fold-change in gene expression in the responders was 
divided by the mean fold-change expression of the 
non-responders and a fold-change threshold of 1.2 was 
applied subsequently to filter the transcripts, which were 
significantly upregulated or down-regulated.
Statistical analysis
All data are described as medians and ranges. Differences 
between patient groups were analysed using Student’s 
t-test and correlations between individual gene transcripts 
and testosterone levels were calculated using Pearson’s 
correlation coefficient in Minitab V.16 (Minitab). Ta
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Results
Description of cases
The majority of the boys had bilateral undescended 
testes, hypospadias, micropenis or a combination of these 
(Table 1). The median age (range) at hCG stimulation was 
0.7 years (0.3, 11.2) and the median EMS was 9 (6, 11). Of 
the 12 boys, 9 (75%) showed a rise in serum testosterone 
after hCG stimulation (responders) and the remaining 3 
(25%) did not (non-responders) (Table  1). Median fold-
change in serum testosterone on Day 4 was 8.3 (4.9, 26.6) 
in the responders. Medium AMH in the responders and 
non-responders was 690 pmol/L (24, 1628) and 4 pmol/L 
(4, 256) (P < 0.01). A genetic mutation in AR was excluded 
by genetic analysis in all the boys who underwent 
AR gene sequencing (8 out of 9 responders and all the 
non-responders).
Relationship of pre-hCG and post-hCG transcriptome 
to clinical characteristics
Unsupervised hierarchical clustering analysis did not 
reveal any clustering patterns in the gene transcripts. On 
assessing the transcriptome pre-hCG and comparing the 
pattern in those with an EMS of 8 or more with those 
with an EMS of less than 8, and applying a fold-change 
filter of 1.5, there were no significant differences detected. 
Further analysis was performed to determine whether 
there was any age dependency in the transcriptome and 
the pattern was compared for those with an age less 
than 1  year with those who were aged 1  year or older 
and no significant differences were found for the pre-
hCG gene transcripts. There were also no differences 
between the pre-hCG transcripts with a detectable 
and undetectable testosterone. When the post-hCG 
transcriptome was studied, 2 transcripts were identified 
from the Y chromosome, which were age dependent, and 
2 transcripts were identified from chromosomes 6 and 12, 
which were dependent on the basal testosterone level. 
These results are shown in Table 2.
Comparison of hCG responders to non-responders
The overall pattern of up- and downregulation of genes in 
the responders and non-responders did reveal differences 
(Fig. 1). On correction for gene expression changes in the 
non-responders, all 9 of the responders demonstrated a 
20% or greater increase in the expression of piR-37153 
and piR-39248, non-coding PIWI-interacting RNAs. 
In addition, 8 (89%), 6 (67%) and 4 (44%) of the responders 
demonstrated a 30, 40 and 50% rise, respectively, in a total 
of 2 other piRNAs (Table 3). In addition, 3 (33%) of the 
Table 2 Relationship of post-hCG transcriptome to EMS, age, basal T and peak T.
 Transcript ID Gene Description FDR Chr
EMS <8 vs ≥8 – – – – –
Age <1 vs ≥1 TC0Y000099.hg.1
TC0Y000204.hg.1
uc011nby.2
uc011nbq.1
piR-46014
piR-46014
<5
<5
Y
Y
Basal T UD vs ≥0.5 TC12000057.hg.1
TC06001608.hg.1
uc010sem.1
uc003ofi.1
piR-47601 <5
<5
12
6
Peak T UD vs ≥0.5 – – – – –
Post test genes were analysed to look at the effects of EMS, age, basal T and peak T using ≥1.5 fold difference filter. The transcript ID is given as well as 
the gene name (12) where available.
Chr, Chromosome number; EMS, External Masculinisation Score; FDR, False Discovery Rate; T, testosterone; UD, undetectable.
Figure 1
Gene expression changes in patients on hCG stimulation. 
Individual transcripts are shown in rows and each column 
represents a patient. Increasing red intensity corresponds to 
higher relative transcript levels compared to the mean 
expression level. Increasing green intensity corresponds to 
relatively decreased transcript levels. Patients J, K and L are 
those who did not show a rise in serum testosterone following 
hCG stimulation.
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responders showed a 50% or greater rise in the expression 
of SNORD5, a small nucleolar RNA. Fold-change in 
testosterone was compared with fold-change in the 
transcripts listed in Table 3 and a, and positive correlation 
was only detected in the expression of SNORD5 (P = 0.01) 
(Fig. 2).
Discussion
Previous studies that have adopted a non-selective 
transcriptomic approach have shown the existence of 
gender-specific differences in a wide range of genes in 
PBMC (13, 14, 15) and by studying a group of people with 
a wide range of conditions affecting sex development, the 
investigators had hypothesized that these differences were 
a function of programming by androgens, most likely 
during embryonic development (8). Gene expression of 
several genes in a wide range of tissues and experimental 
models has been demonstrated to change following 
testosterone exposure (16, 17, 18). We adopted a different 
approach to previous investigators as we were interested 
in identifying a pattern of change in gene expression that 
would indicate androgen responsiveness. In the current 
study, we have demonstrated that there is indeed a pattern 
of gene expression that can be detected in PBMC and that 
may also be responsive to acute changes in testosterone.
Specifically, we have identified several non-coding 
PIWI-interacting RNA (piRNAs) transcripts that seemed to 
be androgen responsive and only rose in those boys who 
showed a rise in testosterone following hCG stimulation. 
PiRNAs are 24–32 nucleotides in length and are the 
least investigated class of small RNA molecules (19, 20). 
The main function of these non-coding RNAs is gene 
silencing by the repression of transposable elements 
(TEs) in the germ line, and this role is highly conserved 
across all animal species (21, 22, 23). PIWI proteins are 
primarily expressed in germ cells and in both mouse 
and fruit fly, mutations of genes encoding PIWI proteins 
result in de-repression of TEs in the germline, leading to 
male sterility (24, 25). PiRNA expression in rat testes has 
previously been reported to be responsive to testosterone 
exposure, and this response has been postulated as one of 
the mechanisms that allows testosterone to regulate testis 
function (26, 27).
In addition to the piRNAs, the PBMC from the boys 
who showed a rise in testosterone also demonstrated 
a rise in gene expression of SNORD5, and this rise was 
significantly correlated with the rise in testosterone. 
SNORD5 is a small nucleolar RNA (snoRNA), which 
also belongs to the family of small, non-coding RNAs. 
Table 3 Fold change in gene expression in the responders divided by the mean fold change expression of the non-responders.
Gene name Transcript ID Gene symbol Chromosome % Change Number of patients
piR-37153 TC11001678.hg.1 DQ599087 11 ↑ 20 9/9
piR-39248 TC15000925.hg.1 DQ601182 15 ↑ 20 9/9
piR-39248 TC15000925.hg.1 DQ601182 15 ↑ 30 8/9
piR-39248 TC15000925.hg.1 DQ601182 15 ↑ 40 6/9
piR-53026 TC17001289.hg.1 DQ585914 17 ↑ 40 6/9
piR-40996 TC22000745.hg.1 DQ572884 22 ↑ 40 6/9
piR-40996 TC22000745.hg.1 DQ572884 22 ↑ 50 4/9
SNORD5 TC18000313.hg.1 – 18 ↑ 50 3/9
piR-61077 TC09001246.hg.1 DQ594965 9 ↑ 60 3/9
piR-40996 TC22000745.hg.1 DQ572884 22 ↑ 60 3/9
– TC15000899.hg.1 DQ572592 15 ↑ 60 3/9
RNY5 TC12001420.hg.1 NR_001571 12 ↑ 60 3/9
Fold change in gene expression in the responders was divided by the mean fold change expression of the non-responders and a fold-change threshold 
of 1.2 was applied subsequently to filter the transcripts which were significantly up or down regulated. These are shown in the table with the gene 
name, symbol and chromosome number.
Figure 2
Correlation between fold change in SNORD5 gene expression 
and fold change in serum testosterone (P = 0.01).
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SNORD5 is a C/D box type of snoRNA expressed in several 
tissues (28) and although it is primarily associated with 
methylation, these RNAs have also demonstrated gene 
expression flexibility (29). However, its reported function 
of methylation is interesting in the current context, as 
it suggests that this may be one of the mechanisms that 
explains the epigenetic actions of testosterone described 
in previous reports (30, 31).
Human chorionic gonadotropin (hCG) is a 
glycoprotein that has an alpha subunit identical to that 
of LH (32), thus allowing it to be used clinically in the 
hCG stimulation test to assess the ability of the testes 
to produce testosterone (33). This ability to stimulate 
testosterone production has been used to determine the 
presence of functioning testes in boys with a suspected XY 
DSD (34). The hCG stimulation test has also been shown 
to aid the diagnosis of testosterone biosynthetic defects 
such as 5α reductase deficiency and 17β hydroxysteroid 
dehdrogenase deficiency (35). Prognostically, hCG 
stimulation performed in early childhood may predict 
testis function during adolescence (36, 37), and some 
have used it to assess androgen sensitivity by measuring 
the fall in serum SHBG following hCG-stimulated rise 
in testosterone (6). In the case of suspected XY DSD, 
a normal rise in testosterone with no evidence of a 
biosynthetic defect is the commonest outcome of the 
test, and in this case, the boy is often suspected of having 
androgen insensitivity. A firm diagnosis of AIS requires 
the confirmation of a mutation in the androgen receptor 
gene (AR). However, recent studies suggest that the 
molecular genetic abnormality in AR may not necessarily 
reside in the conventional coding region within the gene 
(38). Whilst there is a school of thought that molecular 
genetic investigations can be performed in parallel with 
biochemical evaluation, the current study suggests that 
the utility of conventional biochemical investigations 
such as the hCG stimulation test, itself, can include a 
molecular genetic component that aids the diagnosis of 
androgen deficiency and perhaps, androgen resistance. 
Our cases did not include any with a molecular genetic 
diagnosis of androgen insensitivity due to a mutation in 
AR, and it would be helpful to perform the same study 
in a group of boys with a confirmed abnormality in AR. 
Although androgen-responsive circulating proteins such 
as SHBG have been measured previously (6), this test has 
not been considered to be sufficiently reliable to become 
common practice. More recently, another androgen-
responsive protein in the genital skin fibroblasts has 
been reported to have a greater discriminant value for 
androgen sensitivity (38). Genital skin fibroblast studies 
have also previously reported an androgen-dependent 
transcriptome, which could differentiate between 
people with and without androgen sensitivity (3). Given 
the small number of cases studied in the current report 
and the relatively small, yet consistent, fold changes, 
we did not seek to correlate the array findings with 
quantitative real-time PCR. However, in the current 
study, we do raise the prospect of assessing androgen 
sufficiency and, possibly, even androgen resistance less 
invasively by studying an androgen-responsive change 
in expression of a small panel of genes in PBMCs 
extracted from the serial blood samples collected as 
part of the hCG stimulation test, which is commonly 
performed for investigating male hypogonadism. Given 
that testosterone action in T cells may be mediated 
by a combination of genomic and non-genomic AR 
signalling, the potential for PBMCs as a bioassay of 
androgen signalling needs further exploration (39). 
Furthermore, the current study also lends weight to 
the possibility that androgens may modulate immune 
function (40, 41).
In summary, the existence of an androgen-responsive 
group of small RNAs that are measurable in peripheral 
mononuclear blood cells and that change over the short 
duration of a hCG stimulation test raise the prospect of 
combining the biochemical assessment of testosterone 
production with an objective molecular assessment of 
androgen sufficiency.
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